Futuristic Biotechnology,
Journal Year:
2024,
Volume and Issue:
unknown, P. 29 - 38
Published: Dec. 31, 2024
Common
Sage
(Salvia
officinalis)
belongs
to
the
Labiatae/Lamiaceae
family
Indigenous
Middle
East
and
Mediterranean
regions
but
today
has
been
world-widely
revolutionized.
Salvia
officinalis
exhibited
an
extensive
array
of
functionally
bioactive
chemical
constituents
that
have
employed
in
treatment
multiple
chronic
health
conditions
under
primarily
research
documenting
its
novel
biological
significance
exploring
revolutionary
impacts
on
well-being
revealing
range
pharmaceutical
significance.
These
investigations
demonstrated
besides
curing
relatively
mild
illnesses,
S.
possesses
potentially
natural
remedial
alleviating
health-related
life-threatening
by
possessing
anti-carcinogenic,
anti-depressive,
anti-diabetic
efficacy.
This
review
will
shed
light
pharmaco-medicinal
properties
signifying
anti-oxidative,
immune-modulatory,
anti-tumor,
anti-hyperlipidemic,
Neuro-cognitive
efficacy,
Microbicide
activities,
toxicological
effects
preserve
restore
highlighting
this
plant
as
a
fantastic
herb
with
multi-factorial
wellness
benefits.
Biocell,
Journal Year:
2024,
Volume and Issue:
48(3), P. 403 - 413
Published: Jan. 1, 2024
The
global
incidence
of
lung
cancer
is
marked
by
a
considerably
elevated
mortality
rate.MicroRNAs
(miRNAs)
exert
pivotal
influence
in
the
intricate
orchestration
gene
regulation,
and
their
dysregulation
can
precipitate
dire
consequences,
notably
cancer.Within
this
context,
miRNAs
encapsulated
exosomes
manifest
diversified
impact
on
landscape
cancer,
wherein
actions
may
either
foster
angiogenesis,
cell
proliferation,
metastasis,
or
counteract
these
processes.This
comprehensive
review
article
discerns
potential
targets
for
prospective
development
therapeutic
agents
tailored
cancer.Tumor-suppressive
miRNAs,
such
as
miR-204,
miR-192,
miR-30a,
miR-34a,
miR-34b,
miR-203,
miR-212,
exhibit
heightened
expression
demonstrate
capacity
to
inhibit
cellular
proliferation
invasiveness.Conversely,
deleterious
effects
tumor-promoting
like
miR-21,
miR-106a,
miR-155,
miR-205,
miR-210
be
attenuated
through
application
respective
inhibitors.Distinct
selectively
target
various
oncogenes,
including
NUAK
Family
Kinase
1
(NUAK1),
Snail
Transcriptional
Repressor
(Snai1),
Astrocyte
gene-1
(AEG-1),
Vimentin,
Proliferation
apoptosis
adaptor
protein
15
(PEA-15/PED),
Hypoxia-inducible
factor
1-alpha
(HIF1),
well
tumor
suppressor
genes
phosphatase
tensin
homolog
(PTEN),
Suppressor
cytokine
signaling
(SOCS1),
Tumor
P53
binding
(TP53BP1),
PH
Domain
Leucine
Rich
Repeat
Protein
Phosphatase
2
(PHLP22).This
investigative
approach
proves
invaluable
elucidating
specific
implicated
deregulation
crucial
pathogenesis
cancer.
Prospects in Pharmaceutical Sciences,
Journal Year:
2025,
Volume and Issue:
23(1), P. 80 - 88
Published: Feb. 27, 2025
W
obliczu
stale
rosnącej
liczby
przypadków
rozpoznania
nowotworów
na
świecie
wzrasta
pilna
potrzeba
opracowania
skutecznych
metod
zapobiegania
i
terapii
przeciwnowotworowej.
Warto
zauważyć,
że
około
50%
wszystkich
leków
klinicznych
pochodzi
ze
źródeł
naturalnych,
co
sprawia,
fitochemikalia
stają
się
obiecującą
propozycją.
Jednym
z
potencjalnych
kandydatów
jest
kwas
karnozowy,
fenolowy
związek
diterpenoidowy,
który
obficie
występuje
w
rozmarynie
(Rosmarinus
officinalis
L.).
ciągu
ostatniej
dekady
znacząco
wzrosła
liczba
badań
in
vitro
vivo
dotyczących
aktywności
biologicznej
kwasu
karnozowego
jego
pochodnych.
Udowodniono,
karnozowy
wzmacnia
obronę
antyoksydacyjną,
hamuje
aktywność
enzymów
proteolitycznych,
blokuje
przejście
nabłonkowo-mezenchymalne,
zmniejsza
przyleganie
migrację
komórek,
a
także
zapobiega
inwazji
przerzutom
guza.
Ponadto,
promuje
śmierć
komórek
nowotworowych
drodze
apoptozy
autofagii.
Jego
skuteczność
chemoprewencji,
antyproliferacyjnym
antyinwazyjnym
działaniu
ludzkich
liniach
oraz
syngenicznych
modelach
nowotworów,
połączeniu
efektami
synergicznymi
podczas
stosowania
skojarzonej,
niskie
koszty
pozyskiwania
stosunkowo
łatwy
dostęp
potęgują
potencjalne
zastosowanie
leczeniu
raka.
Jednak
pomimo
obiecujących
wyników
przedklinicznych,
nadal
brakuje
walidacji
klinicznej.
Kilka
kwestii
wymaga
dalszego
zbadania,
takich
jak
farmakokinetyka
organizmach
ludzkich,
dostosowania
dawkowania
bezpieczny
czas
ekspozycji.
Zanim
będzie
mógł
być
stosowany
u
pacjentów,
niezbędna
kompleksowa
ocena
bezpieczeństwa,
uwzględniająca
indywidualne
profile
metaboliczne.
Żywność
funkcjonalna
zawierająca
wydaje
strategią
pozwalającą
zmniejszania
globalnej
zachorowalności
raka,
to
jednak
badania
kliniczne
wykorzystaniem
onkologii
wciąż
są
pełni
uzasadnione.
Food Frontiers,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 2, 2025
ABSTRACT
Cancer
is
a
formidable
adversary,
accounting
for
the
second
highest
number
of
fatalities
worldwide.
A
multitude
studies
have
indicated
that
naturally
sourced
small‐molecule
compounds,
owing
to
their
low
toxicity
and
multi‐target
capabilities,
significantly
aid
in
fight
against
tumorigenesis.
However,
natural
small
molecules
certain
limitations,
such
as
poor
water
solubility
permeability.
These
limitations
curtail
clinical
potency
result
lower
bioavailability
within
human
body.
To
address
these
nano‐encapsulation
techniques
emerged
promising
strategy
enhance
solubility,
stability,
delivery
compounds.
For
instance,
several
preclinical
studies,
encapsulating
resveratrol
liposomal
nanocarriers
increased
its
by
up
50‐fold
enhanced
three
five
times.
This
work
based
on
reports
published
from
1999
2024
PubMed
ISI
Web
Science
databases.
review
examines
anticancer
mechanisms
key
molecules,
including
polyphenols,
alkaloids,
terpenes,
discusses
how
incorporation
into
nanocarrier
systems
improves
efficacy.
Additionally,
this
analysis
provides
comprehensive
overview
nanotechnology
can
overcome
pharmacokinetic
offering
foundation
future
advancements
cancer
treatment.
The
integration
of
Artificial
Intelligence
(AI)
in
healthcare
has
transformed
clinical
practices
by
improving
the
accuracy
diagnosis,
optimizing
surgical
procedures,
patient
experience,
and
accelerating
drug
development.
This
article
provides
a
comprehensive
overview
many
applications
artificial
intelligence
across
several
industries,
including
fast
diagnostics,
where
ML
algorithms
greatly
enhance
velocity
disease
diagnosis.
State-of-the-art
robotic-assisted
minimally
invasive
procedures
that
shorten
patients'
hospitalization
improve
their
chances
recovery,
cutting-edge
AI
monitoring,
medication
also
looks
at
primary
challenges
will
inevitably
encounter,
such
as
differences
product
quality,
shortage
skilled
workers,
privacy
ethical
issues,
need
for
improved
regulatory
frameworks.
Despite
challenges,
contributes
significant
advantages
to
industry,
providing
novel
remarkable
contributions
efficiency
medical
progress
outcomes.
paper
emphasizes
importance
cooperation
overcoming
current
enhancing
acceptability
technology
settings.
ensure
AI-driven
innovations
continue
standards
care.